http://rdf.ncbi.nlm.nih.gov/pubchem/patent/SE-8303136-L

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bde8ecff5b221d2df08e4fde167a2c63
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D317-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D263-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D263-24
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D317-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C67-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C213-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C217-86
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-99
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D263-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D263-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-421
filingDate 1983-06-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ddfdee097054f40675b25805478455ba
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3f92788fab36f05e713a1ca063ec9be6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4c0c1cc3c2543e159f91890364232400
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_65d5bac8e19087a2d9bf0a269340df8f
publicationDate 1983-12-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber SE-8303136-L
titleOfInvention OPTICALLY ACTIVE DERIVATIVES OF N-ARYLATED OXAZOLIDINON-2, SPECIFIC AND REVERSIBLE INHIBITORS OF TYPE B MONOAMINOXYDAS AND THEIR PREPARATION KIT
abstract N-arylated oxazolidine-2-one derivatives corresponding to the formula: <IMAGE> (I) and of S(+) configuration, A representing in this case the hydroxyl radical or of R (+) configuration, A designating then the N-methylamino group, as well as the acid addition salts thereof. Application in therapeutics more particularly as monoamine oxidase inhibitors.
priorityDate 1982-06-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID73949
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458395504
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419526621
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559069
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962

Total number of triples: 31.